Suzhou MedicalSystem Technology Temettü

Temettü kriter kontrolleri 0/6

Suzhou MedicalSystem Technology şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	CN¥0.0391
Ödeme oranı	0%

Son temettü güncellemeleri

Recent updates

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Held Back By Insufficient Growth Even After Shares Climb 29%

Oct 01

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Subdued P/S Might Signal An Opportunity

Jun 26

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

Mar 08

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 603990 şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 603990 şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Suzhou MedicalSystem Technology Piyasaya Karşı Temettü Getirisi

603990 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (603990)	0%
Pazarın Alt %25'i (CN)	0.6%
Pazarın En İyi %25'i (CN)	2.2%
Sektör Ortalaması (Healthcare Services)	1.1%
Analist tahmini (603990) (3 yıla kadar)	n/a

Önemli Temettü: 603990 şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 603990 şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 603990 CN piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 603990 herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Suzhou MedicalSystem Technology Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) announces an Equity Buyback for CNY 30 million worth of its shares.

Recent updates

Third quarter 2024 earnings released: CN¥0.30 loss per share (vs CN¥0.075 loss in 3Q 2023)

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Held Back By Insufficient Growth Even After Shares Climb 29%

Suzhou MedicalSystem Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released: CN¥0.31 loss per share (vs CN¥0.26 loss in 2Q 2023)

New major risk - Revenue and earnings growth

Suzhou MedicalSystem Technology Co., Ltd. to Report First Half, 2024 Results on Aug 10, 2024

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Subdued P/S Might Signal An Opportunity

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.038 loss in 1Q 2023)

Suzhou MedicalSystem Technology Co., Ltd., Annual General Meeting, May 20, 2024

Suzhou MedicalSystem Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) announces an Equity Buyback for CNY 30 million worth of its shares.

Suzhou MedicalSystem Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.075 loss per share (vs CN¥0.008 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.26 loss per share (vs CN¥0.041 profit in 2Q 2022)

Suzhou MedicalSystem Technology Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023

First quarter 2023 earnings released: CN¥0.05 loss per share (vs CN¥0.046 profit in 1Q 2022)

Third quarter 2022 earnings released: CN¥0.011 loss per share (vs CN¥0.012 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.054 (vs CN¥0.046 in 2Q 2021)

Investor sentiment deteriorated over the past week

Mianyang Haoxiang Holdings Co., Ltd agreed to acquire an unknown minority stake in Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) from Weng Kang, Yan Huanghong, Wang Jianhua and Fu Hong for approximately CNY 340 million.

Suzhou MedicalSystem Technology Co., Ltd. announced that it expects to receive CNY 238.92928 million in funding from Mianyang Haoxiang Holdings Co., Ltd

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Now 24% undervalued

Now 22% undervalued

Now 21% undervalued

Second quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.06 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.12 loss in 1Q 2020)

New 90-day low: CN¥29.95

New 90-day low: CN¥30.70

New 90-day low: CN¥31.00

New 90-day low: CN¥37.65

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed an agreement to acquire remaining 49% stake in Haikou Mary Hospital Co., Ltd.

Third quarter earnings released

Suzhou MedicalSystem Technology Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

New 90-day low: CN¥41.30

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed an equity acquisition intention agreement to acquire 51% stake in Heilongjiang Tianyuan Obstetrics and Gynecology Hospital Co., Ltd. from Tibet Daming Investment Management Co., Ltd. and Xue Weiwei for approximately CNY 170 million.

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) signed a letter of intent to acquire 51% stake in a Hospital located in Heilongjiang for approximately CNY 170 million.

Earnings released

Zhongruo (Suzhou) Asset Management Co., Ltd. completed the acquisition of 5.34% stake in Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) from Hangzhou Anshi Investment Management Partnership Enterprise (Limited Partnership).

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin